Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Dividend Payout Ratio: (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688513 Chengdu Easton Biopharmaceuticals Co Ltd SHSE:688513
84 GF Score
Price ¥51.25
GF Value ¥46.94
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Chengdu Easton Biopharmaceuticals Co Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Chengdu Easton Biopharmaceuticals Co's Dividend Payout Ratio for the months ended in Jun. 2026 was .

The historical rank and industry rank for Chengdu Easton Biopharmaceuticals Co's Dividend Payout Ratio or its related term are showing as below:

SHSE:688513' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.26   Med: 0.43   Max: 0.58
Current: 0.33

During the past 9 years, the highest Dividend Payout Ratio of Chengdu Easton Biopharmaceuticals Co was 0.58. The lowest was 0.26. And the median was 0.43.

SHSE:688513's Dividend Payout Ratio is ranked better than
59.35% of 123 companies
in the Biotechnology industry
Industry Median: 0.4 vs SHSE:688513: 0.33

As of today (2026-09-22), the Dividend Yield % of Chengdu Easton Biopharmaceuticals Co is 0.96%.

During the past 9 years, the highest Trailing Annual Dividend Yield of Chengdu Easton Biopharmaceuticals Co was 1.99%. The lowest was 0.54%. And the median was 1.03%.

Chengdu Easton Biopharmaceuticals Co's Dividends per Share for the months ended in Jun. 2026 was ¥.

During the past 12 months, Chengdu Easton Biopharmaceuticals Co's average Dividends Per Share Growth Rate was 14.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -6.80% per year.

During the past 9 years, the highest 3-Year average Dividends Per Share Growth Rate of Chengdu Easton Biopharmaceuticals Co was 41.70% per year. The lowest was -6.80% per year. And the median was 17.45% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Chengdu Easton Biopharmaceuticals Co Dividend Payout Ratio Related Terms

Chengdu Easton Biopharmaceuticals Co Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Chengdu Easton Biopharmaceuticals Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chengdu Easton Biopharmaceuticals Co Dividend Payout Ratio Chart

Chengdu Easton Biopharmaceuticals Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only 0.42 0.29 0.32 0.33 0.31

Chengdu Easton Biopharmaceuticals Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 1.40 - -

SHSE:688513 vs VRTX, REGN, MRNA: Dividend Payout Ratio Comparison

For the Biotechnology subindustry, Chengdu Easton Biopharmaceuticals Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chengdu Easton Biopharmaceuticals Co Dividend Payout Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chengdu Easton Biopharmaceuticals Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Chengdu Easton Biopharmaceuticals Co's Dividend Payout Ratio falls into.


SHSE:688513
84GF Score
Chengdu Easton Biopharmaceuticals Co Ltd SHSE:688513
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chengdu Easton Biopharmaceuticals Co Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Chengdu Easton Biopharmaceuticals Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2025 )/ EPS without NRI (A: Dec. 2025 )
=0.49/ 1.5611981760914
=0.31

Chengdu Easton Biopharmaceuticals Co's Dividend Payout Ratio for the quarter that ended in Jun. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2026 )/ EPS without NRI (Q: Jun. 2026 )
=/ 0.43492837685426
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Overvalued in 2026?

Based on GuruFocus' analysis, Chengdu Easton Biopharmaceuticals Co stock appears to be overvalued. The current stock price of ¥51.25 is trading 9.2% above its estimated GF Value™ of ¥46.94. GuruFocus considers Chengdu Easton Biopharmaceuticals Co to be Fairly Valued.

Key valuation signals for SHSE:688513:

  • Dividend Payout Ratio:
  • GF Value™: ¥46.94 vs. price of ¥51.25 (9.2% above fair value)
  • GF Score™: 84/100 with 4 warning signs

No single metric tells the full story. See the SHSE:688513 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chengdu Easton Biopharmaceuticals Co Business Description

Address No. 8, Xiyuan Avenue, Chengdu High-tech Zone, Sichuan Province, Chengdu, CHN, 611731
Chengdu Easton Biopharmaceuticals Co Ltd is engaged in research and development, production and sales of chemical raw materials and chemical pharmaceutical preparations. The company's products range from Active Pharmaceutical Ingredient to finish dosage forms like capsules, tablets and injections, enabling us to take R&D discovery to industrial level, solving problems during the course of R&D, production and distribution. Its products are categorized under Active Pharmaceutical Ingredients and Fixed Dose Formulation.
84GF Score

Get the complete analysis for SHSE:688513

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥51.25
Price
¥46.94
GF Value